Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,351
Closed -$578K 305
2025
Q4
$578K Sell
1,351
-3,930
-74% -$1.71M 0.15% 185
2025
Q3
$2.36M Buy
+5,281
New +$2.39M 0.6% 35
2021
Q1
Sell
-1,490
Closed -$794K 187
2020
Q4
$794K Sell
1,490
-143
-9% -$70.3K 0.12% 105
2020
Q3
$784K Buy
+1,633
New +$801K 0.12% 76
2019
Q3
Sell
-1,279
Closed -$462K 219
2019
Q2
$462K Buy
+1,279
New +$427K 0.04% 197
2018
Q1
Sell
-3,488
Closed -$848K 206
2017
Q4
$848K Buy
+3,488
New +$792K 0.04% 212
2016
Q3
Sell
-2,633
Closed -$359K 273
2016
Q2
$359K Buy
+2,633
New +$349K 0.01% 151

Other funds holding CHE

WBI Investments's CHE Position: Q1 2026 in Review

WBI Investments sold out of Chemed (CHE) in Q1 2026, closing a stake of 1,351 shares — an estimated $578K sold.

WBI Investments first reported a position in CHE in Q2 2016 and held it in 7 quarters. The position peaked at $2.36M in Q3 2025. 489 funds tracked by Wall St. Rank hold CHE as of Q1 2026.

  • WBI Investments reported no remaining Chemed position as of Q1 2026 after selling out during the quarter.
  • WBI Investments sold 1,351 Chemed shares in Q1 2026, an estimated $578K.
  • WBI Investments first reported a position in Chemed in Q2 2016 and held it in 7 quarters.
  • WBI Investments's Chemed position peaked at $2.36M in Q3 2025.
  • 489 funds tracked by Wall St. Rank held Chemed as of Q1 2026.

Based on WBI Investments's 13F filing for Q1 2026, filed 11 May 2026.